Development and Functional Characterization of a Versatile Radio-/Immunotheranostic Tool for Prostate Cancer Management

Development and Functional Characterization of a Versatile Radio-/Immunotheranostic Tool for Prostate Cancer Management

Due to its overexpression on the surface of prostate cancer (PCa) cells, the prostate stem cell antigen (PSCA) is a potential target for PCa diagnosis and therapy. Here we describe the development and functional characterization of a novel IgG4-based anti-PSCA antibody (Ab) derivative (anti-PSCA IgG...

Full description

Bibliographic Details
Main Authors: Arndt, C. (Author), Bachmann, M. (Author), Bergmann, R. (Author), Berndt, N. (Author), Emmermann, J.-P (Author), Fasslrinner, F. (Author), Feldmann, A. (Author), González Soto, K.E (Author), Harikumar, K.B (Author), Hegedűs, N. (Author), Kegler, A. (Author), Kovács, N. (Author), Kovacs, T. (Author), Loureiro, L.R (Author), Máthé, D. (Author), Merkel, K. (Author), Mitwasi, N. (Author), Neuber, C. (Author), Striese, F. (Author), Szöllősi, D. (Author), Tóth, G. (Author)
Format: Article
Language:English
Published: MDPI 2022
Subjects:
(18)F-JK-PSMA-7
Ac-225
CAR T cell
Cu-64
IgG4
prostate cancer
PSCA
PSMA
theranostics
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items